Publisher Correction: Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy

Documenti analoghi

• Publisher Correction: Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy
  di: Marta Sevieri, et al.
  Pubblicazione: (2024-05-01)
• Combined Method to Remove Endotoxins from Protein Nanocages for Drug Delivery Applications: The Case of Human Ferritin
  di: Filippo Silva, et al.
  Pubblicazione: (2021-02-01)
• Protein-Based Nanoparticles for the Imaging and Treatment of Solid Tumors: The Case of Ferritin Nanocages, a Narrative Review
  di: Francesco Mainini, et al.
  Pubblicazione: (2021-11-01)
• Ferritin Nanocage: A Versatile Nanocarrier Utilized in the Field of Food, Nutrition, and Medicine
  di: Chenxi Zhang, et al.
  Pubblicazione: (2020-09-01)
• Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax
  di: Leopoldo Sitia, et al.
  Pubblicazione: (2021-02-01)